Filing Details

Accession Number:
0000899243-22-018016
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-05-13 16:37:15
Reporting Period:
2022-05-12
Accepted Time:
2022-05-13 16:37:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1840574 Verve Therapeutics Inc. VERV () MA
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1226283 A Burt Adelman C/O Verve Therapeutics, Inc.
500 Technology Square, Suite 901
Cambridge MA 02139
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-05-12 10,000 $12.15 18,700 No 4 P Indirect Burt A Adelman 2002 Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect Burt A Adelman 2002 Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 409,626 Indirect The Burt A. Adelman 2021 GRAT
Footnotes
  1. Represents the weighted average purchase price for shares purchased in multiple transactions. Purchase prices ranged from $12.10 to $12.20 per share. Upon request of the staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.